Long-term follow-up of patients with diffuse fasciitis and eosinophilia associated with L-tryptophan ingestion.
We describe the long-term follow-up of two patients who experienced diffuse fasciitis and eosinophilia while ingesting L-tryptophan for treatment of insomnia. This is one of the first reports in the dermatologic literature of the long-term follow-up of eosinophilic fasciitis in association with L-tryptophan ingestion. Both patients fit the Centers for Disease Control's criteria for eosinophilia-myalgia syndrome. The literature on the eosinophilia-myalgia syndrome is reviewed.
Beko
E
E
Department of Dermatology and Cutaneous Surgery, University of Miami School of Medicine, Florida.
Pervaiz
S
S
Nanda
V
V
Dhawan
S
S
D000328:Adult; D000368:Aged; D004802:Eosinophilia / Q000139:chemically induced* / Q000473:pathology; D016603:Eosinophilia-Myalgia Syndrome / Q000139:chemically induced; D005208:Fasciitis / Q000139:chemically induced* / Q000473:pathology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D014364:Tryptophan / Q000009:adverse effects*
D014364:Tryptophan